Tag: Dr. Michel Pairet
Boehringer Ingelheim acquires oncolytic virus company ViraTherapeutics
German pharma company Boehringer Ingelheim has exercised its option to acquire 100% of Austria-based oncolytic virus company ViraTherapeutics for €210 million in a move to ... Read More